Victhom Human Bionics Appoints Mr. Nader Kameli as Chief Operating Officer of its Neuromodulation Business Unit
QUEBEC, April 17 /PRNewswire-FirstCall/ - Victhom Human Bionics Inc. ("Victhom") announces that Mr. Nader Kameli is joining the Company today as Chief Operating Officer of the Neurobionix business unit of Victhom which is responsible for the development and commercialization of its neuromodulation products.
"We are very pleased to welcome Mr. Nader Kameli to Victhom. With extensive and successful experience at high-profile medical device companies such as Guidant and Boston Scientific, Mr. Kameli brings not only a wealth of experience in product development, but also a keen understanding of the technical challenges and commercial opportunities in the high-growth Neuromodulation industry", stated Mr. Benoit Huet, President and CEO of Victhom. "Nader has the perfect mix of credentials and experience to drive the development and to harness the great potential of our Neurobionix business unit", Huet added. He also mentioned that the arrival of Mr. Kameli will allow Mr. Stephane Bedard to focus on the orthotic and prosthetic business unit of Victhom.
Mr. Kameli joins Victhom after eleven years of service at Guidant, now a Boston Scientific company. At the Cardiac Rhythm Management unit of Boston Scientific, he worked for six years managing product development, with a focus on implantable devices, and the last four years as the Group Manager of Business Development, identifying and utilizing external opportunities to accelerate internal development and to complement internal know-how. In this position, he managed the group involved in early- to late-stage engagements with outside entities including mergers and acquisitions, joint ventures, in-licensing, out-licensing and equity investments. Mr. Kameli has over twenty-five years of experience in safety-critical product development and covering product design, quality assurance, project management and business development. He has worked in large companies such as United Technologies and Boston Scientific as well as smaller companies such as Corometrics Medical Systems and Better Packages. Mr. Kameli's educational background is in electrical engineering and computer science, with emphasis in artificial intelligence, neuroscience and business administration.
About Victhom
Victhom discovers, develops and manufactures bionic devices involved in the treatment of a variety of physical and physiological dysfunctions. Victhom's Neurobionix business unit focuses on the development and commercialization of technologies and products involving implantable devices that feature neurosensing and neurostimulation components, integrated with artificial intelligence. Victhom's Biotronix business unit develops biomechatronic products to support or replace peripheral limbs in what is known as orthotics and prosthetics markets.
Victhom's technologies and products are supported by a broad suite of intellectual property, including a portfolio of 37 granted and 82 pending patents filed in various countries and 13 registered trademarks, worldwide. Victhom has established a comprehensive process to ensure the protection of its intellectual property, pursuing filings for relevant discoveries and improvements.
Website: www.victhom.com Source: Victhom Human Bionics Inc. For more information: Victhom Human Bionics Inc. Benoit Huet President and CEO Tel.: (418) 872-5665 ext. 103 Fax: (418) 872-6926 benoit.huet@victhom.com Media Relations Frédéric Tremblay HKDP Communications and Public Affairs Tel.: (514) 395-0375, ext. 234 ftremblay@hkdp.qc.ca
VICTHOM HUMAN BIONICS INC.CONTACT: Victhom Human Bionics Inc.: Benoit Huet, President and CEO, (418)872-5665 ext. 103, Fax: (418) 872-6926, benoit.huet@victhom.com,www.victhom.com; Media Relations: Frederic Tremblay, HKDP Communicationsand Public Affairs, (514) 395-0375, ext. 234, ftremblay@hkdp.qc.ca; Source:Victhom Human Bionics Inc.